Stay updated on Psilocybin Safety & Efficacy for Body Dysmorphic Disorder Clinical Trial
Sign up to get notified when there's something new on the Psilocybin Safety & Efficacy for Body Dysmorphic Disorder Clinical Trial page.

Latest updates to the Psilocybin Safety & Efficacy for Body Dysmorphic Disorder Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedAdded a Locations section with New York as a site and updated the revision to v3.3.3; the previous New York Locations and HHS Vulnerability Disclosure entries were removed.SummaryDifference0.3%

- Check26 days agoNo Change Detected
- Check47 days agoChange DetectedThe Publications section description was updated to state that PubMed automatically populates publications, and a revision note indicates version v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check54 days agoChange DetectedRemoved the government funding status notice from the page. The core trial details and eligibility criteria remain unchanged.SummaryDifference0.4%

- Check69 days agoChange DetectedThe new screenshot shows a visual redesign and rearranged layout of the study details page, with no change to critical study information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check97 days agoChange Detected- Added a prominent notice about potential outages due to lapse in government funding and updated operating status guidance. - Updated version from v3.1.0 to v3.2.0.SummaryDifference5%

- Check105 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.1%

Stay in the know with updates to Psilocybin Safety & Efficacy for Body Dysmorphic Disorder Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Psilocybin Safety & Efficacy for Body Dysmorphic Disorder Clinical Trial page.